De Mercato R, Cantiello J P, Celentano U, Giani U, Romano A, Guarnaccia D, D'Antonio A
Institute of Social Medicine and Public Security, University Federico II Medical School, Naples.
Minerva Med. 1995 Mar;86(3):89-91.
The purpose of this study was to assess the epidemiology of hepatitis C virus (HCV) in prisoners and outpatients attending our center. 2205 specimens were consecutively obtained under code and screened for anti-HCV by the second generation RIBA test and Hepatitis B core antibody (HBcAb) by CORAB test. After serum samples were tested, we reviewed demographic data and categorized four groups: Intravenous drug abusers (IVDAs), prisoners and apparently healthy subjects and warders. Anti-HCV prevalence was 59.4% in 613 IVDAs, 15.5% in 756 prisoners, 2.6% in 454 healthy subjects and 2.8% in 145 warders. These findings suggest that prisoners may be considered a group at increased risk for HCV infection.
本研究的目的是评估在我们中心就诊的囚犯和门诊患者中丙型肝炎病毒(HCV)的流行病学情况。在编码状态下连续采集了2205份样本,通过第二代重组免疫印迹法(RIBA)检测抗-HCV,并通过CORAB检测乙肝核心抗体(HBcAb)。血清样本检测后,我们回顾了人口统计学数据并将其分为四组:静脉注射吸毒者(IVDA)、囚犯、表面健康的受试者和狱警。613名IVDA中抗-HCV患病率为59.4%,756名囚犯中为15.5%,454名健康受试者中为2.6%,145名狱警中为2.8%。这些发现表明,囚犯可能被视为HCV感染风险增加的群体。